Pipeline intelligence
Jan 06, 2015
Are you ready to embrace Gene Therapy?
Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
